100% satisfaction guarantee Immediately available after payment Both online and in PDF No strings attached
logo-home
Volledige samenvatting - paard & rund - virale ziekten, prionziekten, zoönosen $12.84
Add to cart

Summary

Volledige samenvatting - paard & rund - virale ziekten, prionziekten, zoönosen

 2 views  0 purchase
  • Course
  • Institution

Dit is een uitgebreide samenvatting van de virale ziekten, prionziekten en zoönosen van paard en rund. Gemaakt in het academie jaar 2024 en gegeven door prof Jolien Van Cleemput. Belangrijke zaken staan in het vet en zijn onderlijnd, dit maakt het studeren ook overzichtelijker. Alles wat de prof...

[Show more]

Preview 4 out of 126  pages

  • December 25, 2024
  • 126
  • 2024/2025
  • Summary
avatar-seller
VIRALE ZIEKTEN, PRIONZIEKTEN EN
ZOÖNOSEN
INHOUDSOPGAVE

INLEIDING .................................................................................................................................... 5

HERHALING ALGEMENE VIROLOGIE – BASISPRINCIPES ....................................................................................5

EQUINE INFLUENZA VIRUS / EIV ...................................................................................................17

STRUCTUUR: INFLUENZAVIRUS ............................................................................................................... 17
PATHOGENESE .................................................................................................................................. 18
SYMPTOMEN ..................................................................................................................................... 20
DIAGNOSE........................................................................................................................................ 22
BEHANDELING ................................................................................................................................... 22
PREVENTIE........................................................................................................................................ 23

EQUINE HERPESVIRUS TYPE 1 EN 4 / EHV-1, EHV-4 .......................................................................24

PATHOGENESE .................................................................................................................................. 25
SYMPTOMEN ..................................................................................................................................... 25
HERPESVIRUS REPLICATIE: LYTISCHE REPLICATIE ........................................................................................ 29
OVERZICHT PATHOGENESE ................................................................................................................... 30
CNS = EQUINE HERPES MYLOENCEPHALOPATIE (EHM) ................................................................................. 31
DIAGNOSE........................................................................................................................................ 32
BEHANDELING EN BESTRIJDING .............................................................................................................. 32
PREVENTIE........................................................................................................................................ 33

EQUINE HERPESVIRUS TYPE 2 EN 5 / EHV-2, EHV-5 .......................................................................37

SYMPTOMEN ..................................................................................................................................... 37
PATHOGENESE EHV-5 ........................................................................................................................ 37
DIAGNOSE........................................................................................................................................ 38
BEHANDELING ................................................................................................................................... 39

EQUINE HERPESVIRUS TYPE 3 / EHV-3 ..........................................................................................40

PATHOGENESE: PRIMAIRE REPLICATIE - LATENTIE – REACTIVATIE ...................................................................... 40
SYMPTOMEN ..................................................................................................................................... 40
DIAGNOSE ........................................................................................................................................ 41
BEHANDELING ................................................................................................................................... 41

PAPILLOMAVIRUS EN SARCOÏD ....................................................................................................42

SYMPTOMEN ..................................................................................................................................... 42
DIAGNOSE........................................................................................................................................ 42
BEHANDELING ................................................................................................................................... 42
BOVINE PAPILLOMAVIRUS TYPE 1 EN TYPE 2 ............................................................................................... 42
PATHOGENESE .................................................................................................................................. 43



1

, KLINISCHE TYPEN SARCOÏDEN................................................................................................................ 44
DIFFERENTIAAL DIAGNOSE .................................................................................................................... 45
DIAGNOSE........................................................................................................................................ 45
BEHANDELING ................................................................................................................................... 45

EQUINE ROTA EN CORONAVIRUSSEN ...........................................................................................48

PATHOGENESE .................................................................................................................................. 48
SYMPTOMEN ..................................................................................................................................... 49
DIAGNOSE........................................................................................................................................ 49
IMMUNITEIT ....................................................................................................................................... 50
BEHANDELING ................................................................................................................................... 51
PREVENTIE........................................................................................................................................ 51

EQUINE ARTERITIS VIRUS / EAV ....................................................................................................52

PATHOGENESE .................................................................................................................................. 52
PATHOGENESE EN SYMPTOMEN .............................................................................................................. 54
SYMPTOMEN ..................................................................................................................................... 55
IMMUNITEIT ....................................................................................................................................... 56
DIAGNOSE........................................................................................................................................ 56
CONTROLE EN PREVENTIE ..................................................................................................................... 57

EQUINE INFECTIEUZE ANEMIE VIRUS / EIAV ..................................................................................58

TRANSMISSIE..................................................................................................................................... 58
PATHOGENESE .................................................................................................................................. 59
SYMPTOMEN ..................................................................................................................................... 60
DIAGNOSE........................................................................................................................................ 60
CONTROLE EN PREVENTIE ..................................................................................................................... 61

WESTNIJLVIRUS ..........................................................................................................................62

TRANSMISSIE..................................................................................................................................... 62
SYMPTOMEN ..................................................................................................................................... 63
DIAGNOSE........................................................................................................................................ 64
BEHANDELING ................................................................................................................................... 64
CONTROLE ....................................................................................................................................... 64

BOVINE RESPIRATORY DISEASE / BRD / BOVIENE RESPIRATOIRE ZIEKTE .......................................65

ETIOLOGIE ........................................................................................................................................ 67
VIRUSSEN MET ENKEL TROPISME AHS ...................................................................................................... 67
VIRUSSEN MET O.A. TROPISME AHS ....................................................................................................... 68
TRANSMISSIE..................................................................................................................................... 69
PATHOGENESE - NAÏEF DIER .................................................................................................................. 70
PATHOGENESE – IMMUUN DIER .............................................................................................................. 71
PATHOGENESE – SECUNDAIRE BACTERIËLE INFECTIE .................................................................................... 72
PATHOGENESE – HYPERACUUT VERLOOP .................................................................................................. 72
SYMPTOMEN ..................................................................................................................................... 72
DIAGNOSE........................................................................................................................................ 73
BEHANDELING ................................................................................................................................... 74
PREVENTIE........................................................................................................................................ 74

VIRALE SVS: BOVIENE ROTAVIRUS EN BOVIENE CORONAVIRUS ....................................................78




2

, VIRALE SPIJSVERTERINGSSTOORNISSEN .................................................................................................... 78
PATHOGENESE .................................................................................................................................. 78
SYMPTOMEN ..................................................................................................................................... 79
DIAGNOSE........................................................................................................................................ 79
IMMUNITEIT ....................................................................................................................................... 79
BEHANDELING ................................................................................................................................... 81
PREVENTIE........................................................................................................................................ 81

MOND EN KLAUWZEERVIRUS .......................................................................................................83

TRANSMISSIE..................................................................................................................................... 84
PATHOGENESE: PRIMAIRE REPLICATIE – VIREMIE – SECUNDAIRE REPLICATIE ........................................................ 84
SYMPTOMEN ..................................................................................................................................... 85
DIFFERENTIAAL DIAGNOSE .................................................................................................................... 86
DIAGNOSE........................................................................................................................................ 88
BESTRIJDING ..................................................................................................................................... 90

BLAUWTONGVIRUS .....................................................................................................................92

TRANSMISSIE..................................................................................................................................... 92
PATHOGENESE .................................................................................................................................. 92
SYMPTOMEN ..................................................................................................................................... 93
DIAGNOSE, BEHANDELING EN PREVENTIE .................................................................................................. 94
UITBRAKEN ....................................................................................................................................... 95

BOVIENE PAPILLOMAVIRUSES .....................................................................................................96

TRANSMISSIE..................................................................................................................................... 96
PATHOGENESE BPV1-2 (EN 3 IN AUSTRALIË) ............................................................................................ 96
SYMPTOMEN ..................................................................................................................................... 97
PATHOGENESE BPV4 (SCHOTLAND) ....................................................................................................... 97
SYMPTOMEN ..................................................................................................................................... 97
PATHOGENESE BPV5-6....................................................................................................................... 97
SYMPTOMEN ..................................................................................................................................... 98
PATHOGENESE BPVS .......................................................................................................................... 98
PATHOGENESE BPV3,4 EN 6 ................................................................................................................ 98
PATHOGENESE BPV1,2 EN 5 ................................................................................................................ 98
IMMUNITEIT ....................................................................................................................................... 98
BEHANDELING EN PREVENTIE................................................................................................................. 99

AUJESZKY VIRUS ....................................................................................................................... 100

TRANSMISSIE TUSSEN VARKENS ............................................................................................................ 100
TRANSMISSIE VARKENS – ANDERE ZOOGDIEREN ........................................................................................ 100
PATHOGENESE RUND ........................................................................................................................ 101
SYMPTOMEN RUND ........................................................................................................................... 101
DIAGNOSE...................................................................................................................................... 102
BESTRIJDING ................................................................................................................................... 102

BOVIENE SPONGIFORME ENCEPHALOPATHIE (BSE) .................................................................... 103

PATHOGENESE ................................................................................................................................ 105
PATHOGENESE – NORMALE NEURONALE CEL............................................................................................ 105
PATHOGENESE ................................................................................................................................ 106
SYMPTOMEN ................................................................................................................................... 106



3

, DIAGNOSE...................................................................................................................................... 107
BESTRIJDING ................................................................................................................................... 107
SPECIFIEK RISICOMATERIAAL ............................................................................................................... 108
BESTRIJDING ................................................................................................................................... 108
BSE GEVAAR VOOR DE MENS? ............................................................................................................. 108
VCJD ............................................................................................................................................ 109

BOVINE VIRALE DIARREE VIRUS (BVDV) ...................................................................................... 110

CP EN NCP BIOTYPE......................................................................................................................... 110
PATHOGENESE – NCP EN CP NAÏEF DIER ............................................................................................... 111
PATHOGENESE NAÏEF DRACHTIG RUND – NCP ......................................................................................... 112
SYMPTOMEN ................................................................................................................................... 113
PATHOGENESE NAÏEF DRACHTIG RUND - CP ............................................................................................ 113
PATHOGENESE PERSISTENT VIREMISCH IMMUNOTOLERANT RUND – NCP ........................................................ 113
PATHOGENESE PERSISTENT VIREMISCH IMMUNOTOLERANT RUND – CP & NCP ................................................ 113
DIAGNOSE...................................................................................................................................... 115
BESTRIJDING VOOR 2015: SANERING VAN EEN BVD-POSITIEF BEDRIJF ........................................................... 116
BESTRIJDING NA 2015 ....................................................................................................................... 117

BOVIENE HERPESVIRUS TYPE 1 (BHV-1) ...................................................................................... 118

PATHOGENESE PRIMAIRE INFECTIE ........................................................................................................ 118
PATHOGENESE REACTIVATIE ................................................................................................................ 119
SYMPTOMEN ................................................................................................................................... 120
SYMPTOMEN MENINGO-ENCEPHALITIS (BHV-5) ...................................................................................... 121
SYMPTOMEN IPV (BHV1.2) ............................................................................................................... 121
SYMPTOMEN IPB (BHV1.2) ............................................................................................................... 121
DIAGNOSE...................................................................................................................................... 122
BEHANDELING ................................................................................................................................. 122
PREVENTIE EN ERADICATIE .................................................................................................................. 122
PREVENTIE EN ERADICATIE IN BELGIË ..................................................................................................... 124

BOOSAARDIGE CATARRAALKOORTS (BKK).................................................................................. 125

PATHOGENESE ................................................................................................................................ 125
SYMPTOMEN ................................................................................................................................... 125
DIAGNOSE – BEHANDELING - PREVENTIE ................................................................................................. 126




4

The benefits of buying summaries with Stuvia:

Guaranteed quality through customer reviews

Guaranteed quality through customer reviews

Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.

Quick and easy check-out

Quick and easy check-out

You can quickly pay through credit card or Stuvia-credit for the summaries. There is no membership needed.

Focus on what matters

Focus on what matters

Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!

Frequently asked questions

What do I get when I buy this document?

You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.

Satisfaction guarantee: how does it work?

Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.

Who am I buying these notes from?

Stuvia is a marketplace, so you are not buying this document from us, but from seller charlotte1203. Stuvia facilitates payment to the seller.

Will I be stuck with a subscription?

No, you only buy these notes for $12.84. You're not tied to anything after your purchase.

Can Stuvia be trusted?

4.6 stars on Google & Trustpilot (+1000 reviews)

50843 documents were sold in the last 30 days

Founded in 2010, the go-to place to buy study notes for 14 years now

Start selling
$12.84
  • (0)
Add to cart
Added